A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

Clinical trial NCT02390882 · COMPLETED

Trial details

NCT number: NCT02390882
Sponsor: Hanmi Pharmaceutical Company Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Prostate Hyperplasia

Start date: 2014-10-01
Primary completion: 2015-05-01
Enrollment: 494

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.